Gossamer Bio CSO hits the exit after turbulent year, research exec steps up

Retrieved on: 2021-04-20 14:03:45

Tags for this article:

Click the tags to see associated articles and topics

Gossamer Bio CSO hits the exit after turbulent year, research exec steps up. View article details on hiswai:

Excerpt

Carter joined Gossamer in 2019, after leading the development of immunology and immuno-oncology programs at Lycera. She started her biopharma ...

Article found on: www.fiercebiotech.com